Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Talk:Oroboros Diagnostics"

From Bioblast
Line 19: Line 19:
::::* Instrumental development and market launch of O8k as a research device for applications by early testers. ย 
::::* Instrumental development and market launch of O8k as a research device for applications by early testers. ย 
::::* Formulation and creation of basic documents to start an ISO 13485-compliant product development for medical device. Formulation of a project plan including milestone plan and budget calculation up to CE approval.
::::* Formulation and creation of basic documents to start an ISO 13485-compliant product development for medical device. Formulation of a project plan including milestone plan and budget calculation up to CE approval.
::::* Instrumental development of O8k as a medical device for broader application of mitochondrial diagnostics. Potential development of titration robotics to offer the O8k as a Unified Endpoint Management system. ย 
::::* Instrumental development advancement of O8k as a medical device for broader application of mitochondrial diagnostics. Potential development of titration robotics to offer the O8k as a Unified Endpoint Management system. ย 





Revision as of 07:28, 19 October 2022

                



Talk:Oroboros Diagnostics

Oroboros Diagnostics - instrumental innovation to diagnostic standard

FFG

Oroboros Diagnostics

  • COMET Center (K1) - eCall - Project No. 47281252
  • Duration: 18-24 months
  • Start: tbc


About Oroboros Diagnostics

  • Oroboros Diagnostics will be established as a new branch (GmbH) with a business plan to launch an 8-chamber medical device (O8k) for mitochondrial diagnostics. The O8k as a medical device is required for clinical use, with simplifications (O2 measurement only) and specific optimizations (e.g. optical sensor) compared to the general research instrument O2k. A medical device requires an organizational platform separate from the research-linked model of Oroboros Instruments.


Aims

  • Instrumental development and market launch of O8k as a research device for applications by early testers.
  • Formulation and creation of basic documents to start an ISO 13485-compliant product development for medical device. Formulation of a project plan including milestone plan and budget calculation up to CE approval.
  • Instrumental development advancement of O8k as a medical device for broader application of mitochondrial diagnostics. Potential development of titration robotics to offer the O8k as a Unified Endpoint Management system.


References

Coordinator

Network

Participants

ACMIT


ACMIT GmbH - Austrian Center for Medical Innovation and Technology - www.acmit.at
  • ACMIT is a COMET Center (K1) funded within COMET โ€“ Competence Centers for Excellent Technologies โ€“ by BMK, BMDW as well as the co-financing federal provinces Lower Austria and Tyrol. The COMET programme is managed by FFG.
  • DI Bernhard NuรŸbaumer, MAS, EMBA - Chief Business Development Officer


Oroboros Instruments GmbH - www.oroboros.at


Oroboros project involvement

  • Oroboros Instruments is a partner in the network of ACMIT GmbH - Austria Center for Medical Innovation and Technology.


Oroboros Diagnostics Events

Oroboros Diagnostics Publications

Links

News and articles


Support

This project has received funding from the Austrian Research Promotion Funding Agency (FFG).
FFG-logo.png